New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2014
08:46 EDTTWC, AAPL, MGM, WMT, NOK, BAYRY, DIS, LVS, NYT, BAESY, MRK, BBRY, NWSA, WYNN, AMX, JNPR, NVS, CMCSA, CBS, INTCOn the Fly: Periodicals Wrap
WSJ: Broadcasters (CBS, NWSA, DIS, CMCSA) get first victory over Aereo in Utah federal court...BlackBerry's (BBRY) BBM app gets renewed attention...REUTERS: Bayer (BAYRY), Novartis (NVS) explore bids for Merck's (MRK) consumer unit...Nokia (NOK) reportedly considering buying Juniper (JNPR), combining it with NSN... BAE Systems (BAESY): U.S. unit close to 'bottoming out' this year...BLOOMBERG: Wal-Mart (WMT) weighs support for minimum wage increase...Slim (AMX) to exercise NY Times Co. (NYT) warrants this year...OTHER NEWS: Macau casino license renewals (MGM, WYNN, LVS) seen going smoothly, South China Morning Post reports... Intel (INTC) CEO says relationship with Apple (AAPL) getting 'closer,' Apple Insider reports...Comcast (CMCSA) confident of Time Warner Cable (TWC) acquisition approval, FT reports.
News For CBS;NWSA;DIS;CMCSA;BBRY;BAYRY;NVS;MRK;NOK;JNPR;BAESY;WMT;AMX;NYT;MGM;WYNN;LVS;INTC;AAPL;TWC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | all recent news | >>
July 15, 2015
16:00 EDTINTC, AAPLOptions Update; July 15, 2015
Subscribe for More Information
14:56 EDTINTCIntel July 29.5 straddle priced for 5% movement into Q2
Subscribe for More Information
14:53 EDTINTCNotable companies reporting after market close
Subscribe for More Information
14:38 EDTDISShanghai Disneyland to open in Spring 2016
Subscribe for More Information
12:38 EDTAAPLGundlach says out of Apple position
Subscribe for More Information
11:35 EDTTWCNetflix to support Charter's acquisition of Time Warner Cable, Bloomberg says
Subscribe for More Information
11:01 EDTAAPLApple introduces new iPod touch, unveils new colors for iPod models
Subscribe for More Information
10:01 EDTINTCOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:53 EDTAAPLHSBC UK says Apple Pay support coming within 2 weeks, Apple Insider says
HSBC UK (HSBC) said that Apple Pay (AAPL) support is in its final testing and availability will be coming within two weeks, reports Apple Insider. An HSBC spokesperson said, "We are excited to be one of a small number of Apple Pay launch partners. We have been working closely with Apple and are now properly reviewing and testing our systems before launching in two weeks." Reference Link
09:32 EDTAAPLActive equity options trading on open
Active equity options trading on open: AAPL FB BAC RCPT MU YUM NFLX CELG
09:05 EDTMGMMGM Resorts launches plans for 5,000-seat theater at Monte Carlo
MGM Resorts announced plans for an approximately 5,000-seat theater at Monte Carlo Resort and Casino on the west side of the Las Vegas Strip. While The Park and Arena are expected to open in April 2016, the Monte Carlo theater is projected to host its first act at the end of 2016.
08:26 EDTMGMMGM Resorts shares undervalued, says Stifel
Subscribe for More Information
08:03 EDTJNPRJuniper names Bob Worrall as SVP, Chief Information Officer
Subscribe for More Information
07:58 EDTNVSAnalysts break down impact of $7.2B Receptos buyout
After Celgene (CELG) announced last night that the company has agreed to acquire Receptos (RCPT) for $232 per share in cash, or a total of about $7.2B net of cash acquired, research firms have chimed in with their opinions on how the proposed deal may impact others in the biotech space. Receptos key asset is Ozanimod, which is being studied in Phase III trials for relapsing multiple sclerosis and ulcerative colitis. DERIVATIVE CALLS: Piper Jaffray analyst Edward Tenthoff told investors that he views Celgene's deal for Receptos as good for Arena Pharmaceuticals (ARNA). The analyst notes that Arena's APD334 is already showing dose-dependent decreases in circulating lymphocyte counts and that the company will initiate Phase II studies in ulcerative colitis and Crohn's disease this year. Tenthoff reiterates an Overweight rating and $7.50 price target on Arena, which has a market capitalization around $1B and closed yesterday up 8c to $4.47. In its own note to investors this morning, Nomura said Celgene's deal could put downward pressure on Biogen's (BIIB) long-term multiple sclerosis estimates. Nomura's M. Ian Somaiya contended that one-year Phase II efficacy data for Ozanimod looked as good as Novartis’s (NVS) Gilenya and Biogen's Tecfidera’s Phase III at year 2. Somaiya also wondered if rival Gilead (GILD) could be "looking for something bigger" than Receptos for its own deal, telling investors that the firm views Incyte (INCY) as Gilead's most likely takeout target. Incyte's shares closed up $4.46 at $117.46 yesterday, giving the company a market cap of about $20B. RIVAL BID?: Wedbush analyst Liana Moussatos believes another bidder may seek to acquire Receptos, noting that she previously estimated Receptos could be valued at $348 per share, or about $10.9B, in a buyout. Moussatos noted that Celgene said it expects annual peak sales for Ozanimod to reach about $4B-$6B for RMS and UC, making its acquisition price of $7.2BN only a bit more than about 1X peak sales without accounting for other possible indications or the rest of its pipeline. Moussatos told investors she sees "plenty" of potential upside to justify a rival bidder stepping in and reiterated the firm's Outperform rating on Receptos shares. PRICE ACTION: In pre-market trading, Receptos rose 10% to $228.61 while Gilead gained 1.4% to about $119 per share.
07:31 EDTINTCIntel target lowered, removed from Franchise Pick list at Jefferies
Subscribe for More Information
07:29 EDTNOKNokia's HERE forms Open Mobile Ticketing Alliance
Nokia's (NOK) HERE mapping services announced that along with partners in the public and private sector it is forming the Open Mobile Ticketing Alliance, an effort to develop global standards that would allow people to buy public transit tickets from a single app on their mobile devices in cities worldwide. The aim of the Open Mobile Ticketing Alliance is to enable the vision of 'Register once, travel anywhere' by developing open, interoperable standards with payment vendors and transit operators. Other founding members include transportation service providers Scheidt & Bachmann and Thales (TCSFY), and mobile payment provider Verifone (PAY) Mobile Money. Public transit authorities implementing solutions based on OMTA benefit from lower fare-collection costs, while passengers can get the lowest possible fare based on how often they ride.
06:48 EDTINTCIntel initiated with a Neutral at Mizuho
Subscribe for More Information
06:45 EDTWMTWal-Mart's Yihaodian.com chairman, CEO quit, Reuters says
Subscribe for More Information
06:39 EDTAAPLApple to release new iPod touch, 9to5Mac reports
Subscribe for More Information
06:33 EDTAAPLApple 'in touch' with Iranian distributors to sell products there, WSJ reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use